Sentence examples for examining the duration from inspiring English sources
In the analysis examining the duration of the policy and its strength, a further reduction occurred in physicians' propensity to prescribe lisdexamfetamine.
We identified six prospective cohort and three cross-sectional studies examining the duration of PHN in North America and Europe (table 4).
In order to estimate the impact of postprotocol therapies on the results of the OS analysis, a hypothesis-generating exploratory analysis examining the duration of OS in patients who did not receive poststudy therapy was conducted.
Although bacteremia caused by intravascular catheters is often cited as the commonest cause of BSI in the critical care setting, we were unable to identify any prospective, randomized investigations examining the duration of antibiotic therapy for CRBSI.
A UK study examining the duration of acute cough in pre-school children presenting to primary care facilities found that in 10% of children cough persisted beyond 25 days [ 14].
Future studies examining the duration and magnitude of weight loss among individuals who have a robust response to exenatide treatment, as well as characteristics that predict response, may guide us toward a more personalized approach to pharmacotherapy for the treatment of obesity.
This paper uses event history analysis to examine the duration from sexual involvement to coresidential unions for American men and women.
This study was designed to examine the duration of hoarseness after tracheal intubation and to identify risk factors that may increase the duration of hoarseness.
The aim of this study was to examine the duration of vasodilation induced by sympathetic block with the addition of dexmedetomidine to mepivacaine.
We examined the duration of lingering conflict effects, and the geographical breadth of the observed effects, using geospatially explicit information on conflict location and number of conflict-related casualties.
But when a company demands the right to make an unreasonable profit, as Genentech has in the case of Avastin, then Congress should carefully re-examine the duration of patent protection for that particular drug, especially one that prolongs the life of cancer victims who have few other alternatives.
